Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
92
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma

Hanxiao NieDepartment of Hepatobiliary Surgery,The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, People’s Republic of ChinaCorrespondence[email protected]
,
Tao HeDepartment of Hepatobiliary Surgery,The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, People’s Republic of China
,
Li WangDepartment of Hepatobiliary Surgery,The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, People’s Republic of China
&
Ling ZhangDepartment of Hepatobiliary Surgery,The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, People’s Republic of ChinaCorrespondence[email protected]
Pages 1377-1385 | Published online: 25 Feb 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Dimitrios Papaconstantinou, D. Brock Hewitt, Zachary J. Brown, Dimitrios Schizas, Diamantis I. Tsilimigras & Timothy M. Pawlik. (2022) Patient stratification in hepatocellular carcinoma: impact on choice of therapy. Expert Review of Anticancer Therapy 22:3, pages 297-306.
Read now

Articles from other publishers (5)

Yu-Jie Zhou, Guoli Li, Jiyin Wang, Mengyuan Liu, Zihan Wang, Yu Song, Xulong Zhang & Xi Wang. (2023) PD-L1: expression regulation. Blood Science 5:2, pages 77-91.
Crossref
Jingtao Chen, Chao Niu, Ning Yang, Chunyan Liu, Shan-shan Zou & Shan Zhu. (2023) Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment. Pharmacological Research 189, pages 106674.
Crossref
Neda Minaei, Roya Ramezankhani, Atena Tamimi, Abbas Piryaei, Ali Zarrabi, Amir Reza Aref, Ebrahim Mostafavi & Massoud Vosough. (2023) Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future. European Journal of Cell Biology 102:1, pages 151284.
Crossref
Ma Xiaochen, Sun Xiangyang, Xie Fubo, Jian Wencheng, Wang Qingliang, Xie Yang, Li Caixia & Zhang Kai. (2022) The influence of transarterial chemoembolization on serum levels of soluble programed cell death ligand‐1 in advanced hepatocellular carcinoma patients. Asia-Pacific Journal of Clinical Oncology 18:5.
Crossref
Lei Zhou, Guojie Chen, Tao Liu, Xinyuan Liu, Chengxiao Yang & Jianxin Jiang. (2022) MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma. Frontiers in Genetics 13.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.